Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in Moderate Parkinson's Disease
NCT01174810Phase 2Unknown
- Sponsor
- University College London
- Start
- Jul 2010
- Primary completion
- Mar 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of exenatide in Parkinson's disease (PD), sponsored by University College London. Status: unknown.
02
Drugs
exenatide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01174810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01174810.